اکثر مکاتبات کومش از طریق ایمیل سایت می باشد. لطفا Spam ایمیل خود را نیز چک نمایید.
   [Home ] [Archive]   [ فارسی ]  
:: ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
Subscription::
Contact us::
Site Facilities::
Webmail::
Editorial Board::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 24, Issue 6 (November and December 2022 2022) ::
Koomesh 2022, 24(6): 796-806 Back to browse issues page
Comparison of the effects of two drug combinations metoclopramide-acetaminophen, and metoclopramide-ketamine on postoperative pain, nausea, and vomiting after deep vitrectomy surgery- A randomized controlled clinical trial
Hamid Haji Gholamisaryazdi , Dariush Moradi Farsani , Seyede Shadi Hoseini , Hossein Mahjubipour
Abstract:   (829 Views)
Introduction: According to the high incidence and complications of postoperative pain, nausea, and vomiting the current study aimed to assess the combination of acetaminophen-metoclopramide and ketamine-metoclopramide in comparison with a control group in decreasing post-vitrectomy pain, nausea, and vomiting.
Materials and Methods: The current randomized clinical trial has been conducted on 96 patients undergoing elective deep vitrectomy in three treatment groups of acetaminophen-metoclopramide(n=32) which received acetaminophen (10 mg/kg) and metoclopramide (0.15 mg/kg); ketamine-metoclopramide(n=32) which received ketamine (0.1 mg/kg) and metoclopramide (0.15 mg/kg); and the control group (n=32) who received 100 ml of sterile normal saline, all of the drugs were infused intravenously and within 20 minutes before the end of the procedure.  Pain and nausea intensity based on Visual Analogue Scale (VAS) and vomiting incidence and vital signs in the first postoperative 24 hours were assessed.
Results: Hemodynamic parameters did not statistically differ between the study groups during the first 24 hours after surgery. Significant improvements were noticed in all the groups regarding pain, nausea intensity, and vomiting incidence in all the groups (P-value<0.05); however, the comparison of the groups showed the lowest pain (P-value=0.001), nausea (P-value=0.04) intensity scores and vomiting incidence (P-value=0.01) in ketamine-metoclopramide treated patients.
Conclusion: Based on the findings of this study, both acetaminophen-metoclopramide and ketamine-metoclopramide significantly reduced pain, nausea, and vomiting; however, generally, ketamine-metoclopramide had better results. None of the drug compounds caused serious side effects and hemodynamic disturbances
Keywords: Vitrectomy, Nausea, Vomiting, Pain, Acetaminophen, Metoclopramide, Ketamine
Full-Text [PDF 880 kb]   (431 Downloads)    
Type of Study: Research | Subject: General
Received: 2021/08/26 | Accepted: 2022/06/14 | Published: 2022/11/28
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Haji Gholamisaryazdi H, Moradi Farsani D, Hoseini S S, Mahjubipour H. Comparison of the effects of two drug combinations metoclopramide-acetaminophen, and metoclopramide-ketamine on postoperative pain, nausea, and vomiting after deep vitrectomy surgery- A randomized controlled clinical trial. Koomesh 2022; 24 (6) :796-806
URL: http://koomeshjournal.semums.ac.ir/article-1-7245-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 24, Issue 6 (November and December 2022 2022) Back to browse issues page
کومش Koomesh
Persian site map - English site map - Created in 0.05 seconds with 38 queries by YEKTAWEB 4645